GlassScriptPhysician profile
Monique N Phan
NPI 1144005166
$2,437.28
in general payments reported to CMS, 2019-2025
28 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $194 · 2024: $1,216 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,437.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $340.73 | 2023-2025 | Evenity, Repatha, Otezla |
| Sumitomo Pharma America, INC. | $304.29 | 2024-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $290.63 | 2023-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $221.23 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $163.00 | 2023-2025 | Jardiance, Mounjaro, Kisunla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.85 | 2024-2025 | Xifaxan, Trulance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.14 | 2023-2025 | Jardiance, Tradjenta, Synjardy |
| Novo Nordisk INC | $123.73 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Medtronic, INC. | $96.30 | 2024-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Astellas Pharma US INC | $76.11 | 2025 | Veozah |
| Corcept Therapeutics | $53.07 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $52.05 | 2023-2025 | Inspire |
| Pfizer INC. | $49.44 | 2024-2025 | |
| Abbvie INC. | $48.63 | 2023-2024 | |
| Phathom Pharmaceuticals, INC. | $47.47 | 2024 | Voquezna |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $32.96 | 2024 | |
| Eisai INC. | $27.22 | 2024 | |
| Esperion Therapeutics, INC. | $24.39 | 2024 | Nexletol |
| Xeris Pharmaceuticals, INC. | $24.35 | 2024 | Keveyis |
| Cmp Pharma, INC. | $24.09 | 2024 | Norliqva, Atorvaliq, Tadliq |
| Edwards Lifesciences Corporation | $22.80 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Organogenesis INC. | $21.89 | 2025 | Puraply Wound Matrix |
| Exact Sciences Corporation | $21.71 | 2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $20.72 | 2025 | Watchman Flx |
| Painteq LLC | $17.25 | 2024 | Painteq |
| Axonics, INC. | $15.87 | 2024 | Axonics |
| Impulse Dynamics (USA) INC. | $15.59 | 2023 | Optimizer |
| Smith+Nephew, INC. | $12.77 | 2023 | Journey II, Redapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.